Background: To explore the ethical and policy implications of produce prescription (Rx) programs, PubMed, Embase, and Scopus databases were searched for peer-reviewed literature on existing Rx programs in February 2018.
1,2
Produce Rx programs are unique among preventative interventions in using a partnership model of care whereby an authority figure (ie, the referring physician) rewards and positively reinforces repeated health-seeking behaviors. 3, 4 The interplay between patients' financial incentives and the physician-patient relationship is central to the structure of produce Rx programs. As a result of the relative youth of such programs in preventative medicine, no known research to date has considered the varied perspectives of involved stakeholders or the programs' ethical implications.
This article aims to (1) review the academic literature on published accounts of existing produce Rx programs and their stakeholders and (2) use an ethical matrix to evaluate the ethical implications of produce Rx programs and their potential scale-up in state and federal policy.
Methods
PubMed, Embase, and Scopus databases were used to search the peer-reviewed literature on existing Rx programs in February 2018. In this review, inclusion criteria were at least 1 interaction between a medical professional and patient in a health care setting where a prescription for the consumption of fresh, canned, or frozen fruits and vegetables was issued.
Six stakeholder groups were identified. The analysis separated patients into 3 subcategories: adult patients, child patients, and patient families, including those both with and without children. Health care professionals and local participating farmers are included in this analysis as they are critical to program design. Lastly, although government assistance programs are not yet participating in produce Rx programs, the rapidly growing research on such programs is of interest to agencies seeking new incentive models to promote health and nutrition among beneficiaries. As a result, social services relevant to produce Rx programs include food and nutrition benefits (ie, the Supplemental Nutrition Assistance Program (SNAP) and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) health care insurance (ie, Medicaid and Medicare), and income assistance (ie, Temporary Assistance for Needy Families (TANF)).
The 6 stakeholder groups identified in the review were then used to form an ethical matrix (EM), or an analytical tool that evaluates the ethical considerations of several policy alternatives from the perspective of 4 or more stakeholders. 5 Mepham identified 3 standard principles relevant to stakeholders with an interest in a certain set of public policies, including well-being (maximizing benefits and minimizing harms), autonomy (freedom and choice), and fairness (reducing disparities resulting from socioeconomic status or health condition). 6 EMs evaluate policies with respect to these 3 criteria and are divided by stakeholder group. Each cell in an EM represents beneficial or harmful outcomes from the perspective of a stakeholder group, depending on traditional power dynamics, expected impacts, and the specific contexts and communities where programs are implemented.
Article Characteristics
A total of 19 articles are included in this review. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Fourteen articles evaluated the impact of produce Rx programs, including 10 peer-reviewed articles and 4 conference abstracts (see table 1 ). Five articles-1 study and 4 commentary pieces-were qualitative descriptions of the organizations or systems that operate and facilitate produce Rx programs.
Of the 19 articles, 14 featured patients of low socioeconomic status (SES) at either federally qualified health clinics (FQHCs) or community health clinics (CHCs); 12 identified a specific population with a diet-related health condition; and 9 featured both. Five articles described food environments outside the United States, including Italy and the United Kingdom. All of the 14 evaluative articles were observational or quasiexperimental studies. Study design varied, with 8 retrospective cohort studies, 3 prospective cohort studies, 2 qualitative evaluations, and 1 cross-sectional study.
Average study duration was 11.6 weeks, with a range of 4 to 22 weeks. Studies occurred at various times during the year, including both winter and summer months. Abbreviations: CG = community garden; CHW = community health worker; CSA = community-supported agriculture (in-kind); FM = farmer's market; FQHC = federally qualified health center; FV = fruits and vegetables; GF = gluten-free; GP = general practitioner; lb = pound; mo = month; NP = nurse practitioner; NR = Not reported; Prospect = Prospective; Qual = qualitative; RD = registered dietician; Retro = Retrospective; SES = socioeconomic status; wk = week. a,c Two published accounts of the same study. b In most of the United Kingdom (UK), patients diagnosed with celiac disease can receive gluten-free staple foods through a federally-funded program once prescribed by their GP. Prescriptions are free of charge for children throughout the UK. In Wales, Scotland, and Northern Ireland, prescriptions are free for all patients. In England, each prescription charge costs £8.60 unless income qualifies for reduced or free rates. d The study design was semi-structured interviews.
Rx Type and Design
Five Rx types were identified based on the support of food retail. Farmers' markets (FMs) were the primary source of food for study participants, including onsite FMs at the FQHC or CHC where the physician-patient interaction occurred (n = 4), as well as local, participating FMs (n = 5). Grocery stores were either locally owned (n = 1) or a local branch of a national store (n = 1). Other retail included community garden (CG; n = 2) and mobile market (n = 1). Two studies gave participants a choice of where to shop-at an FM and a CG or a participating grocery. Nine of the programs were subsidized using vouchers. The dollar value of the incentive varied between $10 and $50 per week. Table 2 provides a summary of characteristics of participants in all studies. The most common clinician was a general practitioner or primary care practitioner (n = 12), followed by a community health worker (n = 7), and a registered dietician (n = 5). Most articles (n = 10) used a household income at or below the poverty level for recruitment. Obesity and diabetes were the most common noncommunicable disease criteria (n = 5), followed by hypertension (n = 3), and celiac disease (n = 2). 10 Cavanagh et al, 12 Goddu et al 16 ) included descriptive statistics about Medicaid enrollment.
Participant Characteristics

Stakeholder Groups
The ethical matrix comprising the 6 stakeholder groups and 3 ethical considerations appears in Table 3 . The + and -symbols refer to potential outcomes (benefits and harms, respectively) as a result of produce Rx programs. Patients. Children are dependent on adults for both the physical provision of food and the less tangible components of food choice, including cooking knowledge and grocery shopping. This is particularly true for children with diet-related health conditions who are vulnerable to the cognitive, psychosocial, and physiological effects of poor nutrition, as well as teens and adolescents who independently form their own food behaviors. Produce Rx programs hoping to recruit children have potential to enhance healthpromoting behaviors and attitudes early in life. These programs simultaneously protect and constrain food choices, which results in either resistance or eagerness to change behavior, particularly among teenagers. The extent of family involvement as well as children's age and gender affects their responses. 26, 27 Substantial evidence also indicates that food choice interventions are more successful in both the short-and long-term when family-based approaches are used. 28, 29 Among adult patients, produce Rx programs promote consumption of nutrient-rich foods that can ameliorate existing or high-risk diet-related health conditions. Compared to children, parents or caregivers who receive the Rx have both a larger knowledge base and a greater set of choices in purchasing nutrient-rich foods. However, as the results of this review show, produce Rx programs by design must restrict the locations available for participants to partake in grocery shopping, limiting choices to what is available at an onsite FM or local grocery.
Research on customer experience with store cashiers has found reinforcing feedback loops between feelings of embarrassment, perceived discrimination, and low long-term coupon redemption rates, or coupon stigma. 30 This psychosocial effect is particularly strong in grocery stores, where the "devaluation effect" can supersede expected cost savings for consumers of low SES. 31 The Electronic Benefit Transfer (EBT) card replaced paper vouchers in 2004 for SNAP beneficiaries, partially to reflect technological change and to reduce the stigma of identifiable stamp usage. 32 Future produce Rx designs must consider the role of coupon stigma and the potential usefulness of EBT.
Health care professionals. The 11 health care professionals identified in Table 3 reflect a variety of experiences and career stages. By design, Rx programs provide physicians of all levels an opportunity to prescribe a nonpharmacological intervention. Unlike most medications, prescriptions of nonpharmacological treatments require the collection of qualitative data, including patient expectations and experiences. 33, 34 Repeated interactions through follow-ups tend to enhance physician's emotional intelligence, communication skills, and patient trust. 35 Produce Rx programs provide an alternative to the paternalistic model of the physicianpatient relationship. 36 The partnership model assumes mutual participation, whereby health care professionals and patients are colleagues in pursuit of improved health as a shared goal. 37 Physicians, regardless of experience level, were described in some of the 19 studies reviewed as providing mentorship (n = 1), role modelling (n = 2), and counseling (n = 3).
Only a few Rx programs were implemented in medically underserved areas (MUAs), or communities in which preventative care services are unavailable to low-income, vulnerable groups (eg, rural communities, non-English speaking minorities). 38 Physicians who treat medically underserved populations (MUPs) operate at a near-constant level of resource constraint, including unpredictable budgets and insufficient administrative personnel. These constraints may be exacerbated by an additional preventative program.
Local participating farmers. Recent evaluations indicate that financial incentives at FMs benefited local participating farmers, increasing revenue 39 and community engagement. 40 However, redemption rates tended to be greatest during the summer and fall months. Furthermore, produce Rx programs represent an additional source of income beyond a local food producer's presence at FMs. These programs can may be unreliable from one season to the next, covering only a few weeks or months. While still in pilot phases, produce Rx programs might not recur, contributing to economic instability among local food producers. 41 Some of the produce Rx programs in this review attempted to ameliorate the transportation barriers faced by patients with low income by providing an onsite FM (see table 1 ). However, the reduced transaction costs for patients may have the unintended consequence of increasing fixed costs for farmers. These costs include an increase in transport and storage costs that pose time constraints and restrict choice of market locations. Other produce Rx programs provide an incentive coupon for redemption at local FMs, ameliorating these cost issues.
Participating farmers are most impacted by the cost structure of the incentive-how it is funded, subsidized, or otherwise covered by program partners. In this review, some studies covered the cost of the incentive in the research budget. But the majority of studies did not report who bore the cost burden of the incentive. The farmers who are forced to internalize the cost of subsidized produce may be unable to participate in any incentive program.
Government assistance programs.
As shown in table 2, most existing programs did not work with the assistance programs and systems in place for beneficiaries with low SES despite using SES as a primary eligibility criterion. Produce Rx programs that seek to enroll participants with low SES could make greater use of existing public assistance systems through which incentives could be disbursed, such as SNAP and Medicaid, thereby enlarging public data on the complex intersections between health care, food access, and income. However, administration of federal programs-including determination of participant eligibility, funding, and bureaucratic functions-varies between states and localities. Without substantial policy cohesion from federal to municipal levels, any produce Rx program is likely to be cost inefficient and disorganized, as well as subject to the politics of annual budget negotiations.
Most studies used the umbrella term "low-income" to identify participants (see table 3 ). As Rx programs grow, clinicians must become systematic in selecting participant eligibility criteria. One solution is using the federal government's systems for defining low-income by "who" and "where." The designers of produce Rx programs could identify the overlap between geographic areas or communities defined by the US Department of Agriculture for SNAP and WIC (food deserts) and by the Department of Health and Human Services for Medicaid and Medicare (MUAs, MUPs). However, the complexities of government assistance implementation remain, and procedures must be enacted to modify varying state and local systems.
Conclusions
Compared to other diet-related preventative interventions, produce Rx programs are relatively young. The majority of studies identified in this article were private or smallscale pilots that enrolled a small sample of eligible patients. The author knows of no published studies based on randomized controlled trials that test the effects of varied Rx designs and program structures on outcomes. More research is necessary to evaluate the Rx prescription model with respect to a variety of independent variables, such as (1) standard medical measurements of diet-related health indicators, including body mass index, Hb1AC levels, and blood pressure and (2) evaluations of attitudinal and behavioral change, including whether there is a positive relationship between the dollar value of redeemed incentives and improvements in both nutrition outcomes and confidence in food preparation skills. Other variables to be tested include variations in eligibility criteria, prescription type (coupon, CSA, voucher) and dollar value, timeline of redemption, extent of nutrition education associated with the prescription, integration with federal assistance programs, use of electronic medical records to inform prescription type, and food retail location(s) accepting the prescription in place of a monetary exchange.
This review also found that no programs are yet linked to federal assistance program systems, including Medicaid, SNAP, and WIC. Policymakers should consider whether to replace the prescription with an EBT card or a more discreet incentive to ameliorate potential coupon stigma concerns. Further research must determine whether a prescription remains effective if it only provides guidance, instructions, recipes, or servings of seasonally available foods rather than serving the purpose of a financial exchange.
Cost appears to be a primary policy barrier to scaling up produce Rx programs nationwide. Results from this review indicated that other stakeholders or grants provided the funds to subsidize the FVs, but varying program design could leave local participating farmers at risk of bearing the cost burden. As produce Rx programs begin to grow in size and scope, researchers, clinicians, and other health care stakeholders should partner to design the incentive structure, acknowledging the critical role played by physicians, local participating farmers, and government assistance programs.
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